GLP-1 medications have been a gamechanger in the fight against obesity. But for a minority of patients, their impact is negligible. Why?

A study conducted by researchers at Oxford University revealed that patients who stop taking GLP1-based weight-loss drugs, such as Ozempic, regain the weight they lost in less than two years. The ...

Older female mice—equivalent in age to 60-year-old women—given daily injections of the active ingredient in Ozempic lived ...

Jelly Roll is addressing speculation that Ozempic contributed to his dramatic weight loss. The 41-year-old country star, ...

Exclusive: Some users of injectable weight loss drugs are failing to lose any meaningful kilos despite forking out thousands ...

The arrival of GLP-1s into the market plus falling victim to an online scam caused a drop in revenue of 50pc at her clinics, ...

Novo Nordisk says 40% of children ages 6-12 who adhered to semaglutide treatment were no longer classified with obesity after ...

"Ozempic feet" is an informal term describing heel pain and foot discomfort caused by the rapid loss of protective subcutaneous fat padding in the feet during GLP-1 weight loss therapy. Rapid body fat ...

Renée Fabian is Lead Editor for Pet Health at Forbes Advisor. She has over 10 years experience as a journalist and editor covering pet and human health topics. Renée previously worked as senior pet ...

The term "miracle" is often applied to the new generation of weight-loss medications used to treat obesity and diabetes. But ...

The Herald Sun can reveal the infamous mushroom cook and self-professed binge eater recently started the weight loss jabs in solitary confinement. The revelations come as she awaits news on whether ...

Renée Fabian is Lead Editor for Pet Health at Forbes Advisor. She has over 10 years experience as a journalist and editor covering pet and human health topics. Renée previously worked as senior pet ...